- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
China One-on-One's BIO CEO how-to's & tutorials profile BIO International Convention vaccines Partnering Business Forum 2011 2012 BIO International Convention India cancer biotech industry business development webinar Events BIO Events 2011 BIO International Convention BIO Investor Forum 2012 Business ForumAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Archive
- May 2012 (2)
- April 2012 (2)
- March 2012 (2)
- February 2012 (1)
- December 2011 (2)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- July 2011 (1)
- June 2011 (4)
- May 2011 (5)
- April 2011 (4)
- March 2011 (2)
- December 2010 (1)
- September 2010 (1)
- April 2010 (5)
- March 2010 (6)
- February 2010 (1)
- January 2010 (2)
Category Archives: What would George do?
BIO CEO Company Snapshot: ImmunoGen, Inc.
In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New York City, we’re profiling ImmunoGen, Inc. which will be presenting at the event. We spoke with ImmunoGen, Inc. CEO Daniel Junius and he outlined his organization’s priorities and challenges as well as how his company differentiates themselves from the competition. Company Snapshot What are the short-term and long-term priorities for your company? Our highest priority today is building and advancing our pipeline Read More >